1. Amgen V. Connecticut Retirement Plans and Trust, 133 S. Ct. 1184, 568 U.S., 185 L. Ed. 2d 308 (2013).
2. Angell, M. (1997). The ethics of clinical research in the third world. New England Journal of Medicine, 337, 847–848.
3. Angell, M., & Relman, A. S. (2002). Patents, profits and American medicine: Conflicts of interest in the testing and marketing of new drugs. Daedalus, 131, 102–111. http://www.jstor.org/stable/20027764 .
4. Arnold, D. G., Audi, R., & Zwolinski, M. (2010). Recent work in ethical theory and its implications for business ethics. Business Ethics Quarterly, 20(4), 559–581. doi: 10.5840/beq201020438 .
5. Association for Molecular Pathology v. Myriad Genetics, Inc., 133 S. Ct. 1747 (U.S. 2013).